Literature DB >> 29016990

Age and sex differences in atrial fibrosis among patients with atrial fibrillation.

Nazem Akoum1, Christian Mahnkopf2, Eugene G Kholmovski3, Johannes Brachmann2, Nassir F Marrouche3.   

Abstract

Aim: Age and female sex are associated with a higher risk of stroke in atrial fibrillation (AF). We sought to determine whether advancing age and female sex are associated with higher atrial fibrosis. Methods and results: We conducted an observational cohort study of patients with AF enrolled in the University of Utah AF Database and a non-AF control group who underwent late-gadolinium enhancement magnetic resonance imaging (LGE-MRI) for atrial fibrosis quantification. Participants with contra-indications for contrast MRI scanning were excluded. Nine hundred and eight consecutive men and women with AF and 15 non-AF controls were included in this study. Left atrial fibrosis increased with age in both men and women with AF. Women with AF (n = 316) were older than men (n = 592): mean age 68.7±11.6 vs. 64.9±11.7 years; P < 0.01, and had higher left atrial fibrosis compared with men 17.5 ± 10.1% vs. 15.3 ± 8.9%; P < 0.001. Women also had a higher prevalence of prior stroke compared with men (15.8% vs. 6.5%; P < 0.001). Age and sex relationships with atrial fibrosis remained significant in multivariate analysis. Compared with the non-AF control group, patients with AF had significantly higher atrial fibrosis: 16.0 ± 9.4 vs. 5.5 ± 5.8%; P < 0.001. Conclusions: Advancing age and female sex are associated with a higher burden of atrial fibrosis in patients with AF. Women with a prior history of stroke also have higher fibrosis compared with both women and men without history of stroke. Advanced fibrosis may explain the female and age association with stroke in AF.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29016990     DOI: 10.1093/europace/eux260

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  19 in total

1.  Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.

Authors:  Jim W Cheung; Edward P Cheng; Xian Wu; Ilhwan Yeo; Paul J Christos; Hooman Kamel; Steven M Markowitz; Christopher F Liu; George Thomas; James E Ip; Bruce B Lerman; Luke K Kim
Journal:  Eur Heart J       Date:  2019-09-21       Impact factor: 29.983

2.  Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the German Ablation Registry.

Authors:  Thomas Fink; Andreas Metzner; Stephan Willems; Lars Eckardt; Hüseyin Ince; Johannes Brachmann; Stefan G Spitzer; Thomas Deneke; Claus Schmitt; Matthias Hochadel; Jochen Senges; Andreas Rillig
Journal:  Clin Res Cardiol       Date:  2019-04-05       Impact factor: 5.460

Review 3.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

4.  The impact of height on recurrence after index catheter ablation of paroxysmal atrial fibrillation.

Authors:  Ching-Han Liu; Li-Wei Lo; Fa-Po Chung; Shih-Lin Chang; Yu-Feng Hu; Yenn-Jiang Lin; Shih-Chung Huang; Su-Ting Gan; Chin-Yu Lin; Tze-Fan Chao; Jo-Nan Liao; Ta-Chuan Tuan; Chih-Min Liu; Yang-Che Shiu; Cheng-I Wu; Ling Kuo; Jennifer Jeanne B Vicera; Isaiah Lugtu; Cheng-Hung Li; Yu-Cheng Hsieh; Yi-Jen Chen; Shih-Ann Chen
Journal:  J Interv Card Electrophysiol       Date:  2021-09-01       Impact factor: 1.759

Review 5.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 6.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

7.  Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial.

Authors:  Andrea M Russo; Emily P Zeitler; Anna Giczewska; Adam P Silverstein; Hussein R Al-Khalidi; Yong-Mei Cha; Kristi H Monahan; Tristram D Bahnson; Daniel B Mark; Douglas L Packer; Jeanne E Poole
Journal:  Circulation       Date:  2021-01-27       Impact factor: 29.690

Review 8.  Women and atrial fibrillation.

Authors:  Annabelle Santos Volgman; Emelia J Benjamin; Anne B Curtis; Margaret C Fang; Kathryn J Lindley; Gerald V Naccarelli; Carl J Pepine; Odayme Quesada; Marmar Vaseghi; Albert L Waldo; Nanette K Wenger; Andrea M Russo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-12-29       Impact factor: 2.942

9.  Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?

Authors:  Nicklas Vinter; Anne Sofie Frederiksen; Andi Eie Albertsen; Gregory Y H Lip; Morten Fenger-Grøn; Ludovic Trinquart; Lars Frost; Dorthe Svenstrup Møller
Journal:  Open Heart       Date:  2020-06

10.  Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry.

Authors:  A Sultan; J Lüker; D Andresen; K H Kuck; E Hoffmann; J Brachmann; M Hochadel; S Willems; L Eckardt; T Lewalter; J Senges; D Steven
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.